New heart ablation technique aims to zap troubling rhythms

NCT ID NCT06747013

ENROLLING_BY_INVITATION Disease control Sponsor: Vivek Reddy Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new type of catheter that uses pulsed electrical fields to treat certain heart rhythm problems, specifically premature ventricular contractions (PVCs) and ventricular tachycardia. The device, called Farapoint, is designed to map and ablate (destroy) the tiny areas of heart muscle causing the abnormal rhythms. Researchers will enroll 60 people and follow them for 3 months to see if the procedure reduces or eliminates these arrhythmias without needing more medication. The study also closely tracks any side effects or complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pulsed field ablation catheter (Farapoint)

What this could lead to

If successful, this could provide a new, potentially safer way to treat certain heart rhythm problems without long-term medication.

What could go wrong

This is an early study with only 60 participants, so results may not apply to everyone. There are risks of serious side effects from the procedure itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE VENTRICULAR CONTRACTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ventricular Premature Complexes ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States